Breakthrough elderberry extract sets a new standard in potency, purity, and sustainability
JULY 23, 2025 – ANAHEIM, CA – Cyvex Nutrition, a member of the Bioriginal Group of Companies and trusted provider of high-quality nutraceutical ingredients, is excited to announce a strategic partnership with Finnish ingredient innovator Eevia Health Plc to bring FENO-SAMBUCUS™ 30—a potent, extra-strength, excipient-free elderberry extract—to the North American market. This collaboration combines Eevia’s advanced extraction technology with Cyvex’s legacy of polyphenol-rich botanicals to deliver an immune health ingredient tailored for formulators focused on clean labels, reliable supply, and measurable efficacy.
Recognized for its immune-supportive properties, elderberry is a key ingredient in many dietary supplements and functional products. FENO-SAMBUCUS™ 30 stands apart from competitors with double the anthocyanin and polyphenol content of typical elderberry extracts, standardized to ≥30% anthocyanins and ≥50% total polyphenols, including high levels of proanthocyanidins. This higher strength allows for reduced dosage volumes, unlocking new formulation opportunities and greater cost-efficiency for manufacturers.
Developed using Eevia’s proprietary extraction and purification process, FENO-SAMBUCUS™ 30 delivers a broader spectrum of bioactive polyphenols than conventionally extracted products. The Eevia process also removes virtually all sugars and organic acids, resulting in a 100% elderberry extract that is excipient-free and virtually sugar-free—no carriers or adulterants—setting a new benchmark for purity and clean labeling.
In vitro testing conducted by an accredited third-party laboratory confirmed FENO-SAMBUCUS™’s superior bioactivity across 148 human biomarkers, validating its effectiveness in supporting immune health and overall wellness. Manufactured in Finland using green-chemistry methods and cultivated European elderberries, the ingredient also boasts one of the lowest carbon footprints in the industry, aligning with growing ESG priorities.
“FENO-SAMBUCUS™ 30 fits perfectly into our mission of delivering nature-made, science-backed ingredients,” said Matt Phillips, President of Cyvex Nutrition. “It’s not just about potency; it’s about delivering purity, sustainability, and validated bioactivity. This partnership allows us to bring those benefits to North American manufacturers developing the next generation of immune health products.”
For more information on FENO-SAMBUCUS™ 30, please visit www.cyvex.com/product/elderberry-extract or contact +1 (949) 622-9034.
-30-
About Cyvex Nutrition
Cyvex Nutrition, a member of the Bioriginal Group of Companies, is a trusted provider of high-quality nutraceutical ingredients. Originally founded in 1984, Cyvex built a strong reputation as an industry leader in condition-specific, science-backed ingredients derived from natural sources. Cyvex recently relaunched as a standalone subsidiary as part of Bioriginal’s commitment to innovation, quality, and sustainability in the nutraceuticals industry. With a focus on delivering premium solutions to the dietary supplement, functional food, and beverage industries, Cyvex Nutrition continues to empower brands with cutting-edge ingredients that support health and wellness.
About Eevia Health Plc
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild-harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
Eevia Health manufactures 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga mushroom, and pine bark, are wild-harvested sustainably.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden (Ticker EEVIA).
Contact
Anna Buchholz
Marketing Communications Specialist
Bioriginal Food & Science Corp
102 Melville Street, Saskatoon, SK Canada
T +1-306-975-9252 | Anna.Buchholz@bioriginal.com
